SODIUM POLYSTYRENE SULFONATE
NDC 11534-166, sodium polystyrene sulfonate, powder, for suspension, from SUNRISE PHARMACEUTICAL, INC..
- Product NDC
- 11534-166
- Status
- Listed
- Labeler
- SUNRISE PHARMACEUTICAL, INC.
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL, RECTAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204071
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/11534-166 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM POLYSTYRENE SULFONATE4.1 meq/g
| Package NDC | NDC-11 | Package |
|---|---|---|
| 11534-166-15 | 11534016615 | 15 g in 1 BOTTLE (11534-166-15) |
| 11534-166-16 | 11534016616 | 15 g in 1 BOTTLE (11534-166-16) |
| 11534-166-44 | 11534016644 | 454 g in 1 JAR (11534-166-44) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/c73b9661-2378-4336-8be0-098e7c1ae522NADAC price for package 11534016616
GET /v1/drugs/nadac/11534016616NADAC price for package 11534016644
GET /v1/drugs/nadac/11534016644
Use it
Look up 11534-166 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/11534-166 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 11534-166. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.